The MHRA categorizes medicine recalls into three main classes: National Patient Safety Alert (NatPSA)(equivalent to Class 1 Medicines Recall), Class 2, and Class 3. Each class represents a different level of risk, and the urgency of the action required depends on the severity of the defect. There is also a fourth level, known as Medicines Notification: Caution in use (Class 4).

A table explaining the new Medicines Recall and Notification classifications and the associated defect risk classification can be found on the GOV.UK website.

The Recall Process

Once a medicine defect is identified, the MHRA works with manufacturers, wholesalers and healthcare professionals to assess the risk and determine the appropriate recall classification. The MHRA then issues a Medicines Recall or Notification to inform suppliers, healthcare providers, pharmacies, and the public. For urgent recalls, such as a National Patient Safety Alert (NatPSA)(equivalent to Class 1 Medicines Recall), notifications are sent out immediately to ensure the defective products are removed from shelves and recalled from patients as quickly as possible.

Suppliers, clinics, hospitals, and pharmacies are required to follow the recall instructions, which may include stopping the use of the medicine, returning stock, or advising patients to switch to an alternative treatment. Public communication is a key part of the recall process, ensuring that patients are made aware of any risks and advised on what steps to take if they have already used the affected medicine.

Figure 1: The new Medicines Recall and Notification classifications and the associated defect risk classification. Source: MHRA

1. The Impact of Temperature on Medicine Efficacy

Medicines are highly sensitive to environmental conditions, particularly temperature. When stored outside their recommended temperature range, many drugs can degrade, lose potency, or even become toxic. Temperature extremes — whether too hot or too cold — can lead to the following issues:

• Chemical Degradation: Many medications consist of complex chemical compounds that are sensitive to heat and light. Exposure to high temperatures can accelerate chemical breakdown, rendering the medicine less effective or even harmful. For example, insulin, a hormone used to manage diabetes, loses its effectiveness when exposed to temperatures above 25°C (77°F) for prolonged periods.
• Physical Changes: Medications in liquid form, such as suspensions, emulsions, or injectable solutions, can undergo physical changes if stored improperly. Freezing can cause solutions to crystallize or precipitate, while excessive heat can lead to evaporation, separating components, or damaging active ingredients. Vaccines, for instance, can lose their immunogenic properties if exposed to freezing conditions.
• Microbial Contamination: Some medications, especially those that are biologically derived, are prone to microbial growth when stored at incorrect temperatures. Uncontrolled temperatures can foster bacteria, fungi, or mould in certain products, risking contamination and infection when administered to patients.
• Wastage and Unnecessary Cost: Medicines exposed to extremes of temperatures may be rendered unusable and will have to be disposed, leading to stock shrinkage and financial losses.

2. Ensuring Patient Safety

The primary concern of healthcare providers is the safety of the patient. Improperly stored medicines can lead to adverse drug reactions or ineffective treatment, putting patients at risk. For example:

• Antibiotics that lose potency due to heat may fail to fully eradicate infections, leading to prolonged illness or the development of antibiotic resistance.
• Biological drugs like monoclonal antibodies, used in cancer and autoimmune disease treatments, can degrade rapidly in fluctuating temperatures, causing loss of function and inadequate dosing for patients.
• Cardiovascular medications such as glyceryl trinitrate, which is sensitive to light and heat, can become ineffective in an emergency if stored improperly, putting patients at risk of exacerbating angina.

Healthcare professionals are responsible for ensuring that medicines administered to patients are both safe and effective. Proper storage is an integral part of this responsibility.

3. Regulatory Compliance

Regulations for the storing of medicines, such as those set by the World Health Organization (WHO) and national health bodies like the FDA, European Medicines Agency (EMA) and the Medicines and Healthcare products Regulatory Agency (MHRA), mandate strict temperature controls for the storage and transport of medicines. Failure to comply with these guidelines not only endangers patients but can also lead to legal ramifications for healthcare providers and institutions. Moreover, improper storage may result in the loss of expensive drugs and supplies, resulting in significant financial loss for healthcare facilities.

Common regulatory storage conditions include:

• Cold Chain Storage (2-8°C): Used for vaccines, insulin, and many biologics.
• Controlled Room Temperature (15-25°C): Appropriate for the majority of oral medications and topical agents.
• Freezer Storage (-20°C or lower): Required for some vaccines and specific research drugs.

Proper monitoring, documentation, and audits of temperature conditions in storage areas are necessary to meet regulatory standards and avoid penalties.

4. Technology and Temperature Monitoring

Technological advancements have made it easier than ever to maintain optimal storage conditions for medications. Digital thermometers, data loggers, and automated temperature monitoring systems can ensure that storage facilities remain within specified temperature ranges. These tools provide real-time alerts if temperature deviations occur, allowing timely interventions to prevent the degradation of stored medications.

In addition, backup generators or alternative power supplies are essential in healthcare facilities to prevent disruptions in storage conditions during power outages. This is particularly critical for medications like vaccines, which must remain within a strict temperature range to retain their effectiveness.

5. Staff Training and Protocol Implementation

Healthcare staff should be regularly trained on the importance of proper storage procedures and the consequences of improper temperature management. This includes:

• Understanding the temperature requirements of each medicine in the facility.
• Recognizing signs of compromised medications, such as feeling the product temperature by touch, detecting discoloration, crystallisation, or unusual odours.
• Ensuring that refrigerators and storage units are not overloaded or improperly organized, which can block airflow and lead to temperature variations.
• Establishing clear protocols for checking and documenting storage conditions regularly.

Having a Standard Operating Procedure (SOP) for storing temperature-sensitive medicines, coupled with regular audits and reviews, can significantly reduce the risks associated with improper storage.

Conclusion

For healthcare professionals, ensuring that medicines are stored at the correct temperature is a critical aspect of patient safety and treatment efficacy. By maintaining proper temperature control, healthcare providers can preserve the potency, safety, and stability of drugs, thus ensuring that patients receive the full therapeutic benefit of their medications. Investing in reliable temperature monitoring systems, educating staff, and adhering to regulatory guidelines are necessary steps in safeguarding both medicines and patients.

Burlington Pharma’s expertise in creating customised solutions, providing regulatory guidance, and offering staff training makes them an invaluable partner for clinics aiming to ensuring medicines are kept at the right temperature and improve patient care.

These disruptions can lead to delays in patient care, increased costs, and heightened staff stress. However, by implementing effective strategies and collaborating with wholesale partners like Burlington Pharma, healthcare providers can significantly improve their ability to manage medicine supply shortages, maintain patient care, and optimise operational efficiency.

Figure 1: Shortage Management Process from ‘A Guide to Managing Medicines Supply and Shortages’ by the NHSE&I Medicines and Diagnostics Policy Unit and DHSC Medicines Supply Team, published November 2019.

Key Strategies for Managing Medicine Shortages

• Proactive Planning: Develop a comprehensive shortage management plan that outlines roles, responsibilities, and procedures for addressing supply disruptions. Identify critical medications and patient populations most vulnerable to shortages.
• Effective Communication: Establish clear communication channels with staff, patients, and suppliers. Timely information sharing about shortages can help manage expectations and avoid unnecessary anxiety.
• Risk Assessment and Prioritisation: Continuously assess the risk of shortages for essential medications. Prioritise the allocation of available supplies to ensure the needs of the most vulnerable patients are met.
• Alternative Treatments: Explore clinically appropriate alternatives, such as different formulations or dosages, to maintain patient care.
• Inventory Management: Optimise inventory levels to balance the need for adequate supply with cost-effectiveness. Consider implementing just-in-time inventory systems for non-critical medications.
• Collaboration: Work closely with suppliers, wholesalers, and other healthcare providers to share information, identify solutions, and optimize supply chains.

The Role of Pharmaceutical Wholesalers

Pharmaceutical wholesalers play a vital role in mitigating medicine supply shortages. Companies like Burlington Pharma can offer several advantages to healthcare providers:

• Supply Chain Expertise: Wholesalers have a deep understanding of the pharmaceutical supply chain, enabling them to identify potential disruptions early and implement proactive measures.
• Inventory Optimisation: By maintaining robust inventory levels and optimising stock distribution, wholesalers can help reduce the risk of stockouts. We work with individual healthcare providers to come up with personalised solutions.
• Product Substitution: Burlington Pharma can often provide alternative products or formulations when faced with shortages, ensuring continuity of care.
• Data Analytics: Advanced data analytics can help wholesalers identify trends, predict shortages, and optimise stock levels, benefiting their customers.
• Dedicated Support: Burlington Pharma offers dedicated support teams to assist healthcare providers in managing shortages, providing guidance and resources.

Burlington Pharma is committed to supporting healthcare providers in overcoming the challenges posed by medicine supply shortages. By leveraging our expertise, resources, and partnerships, we aim to ensure the uninterrupted supply of essential medicines to patients.